APPLIED THERAPEUTICS ($APLT) is expected to release its quarterly earnings data on Friday, March 14th after market close, per Finnhub. Analysts are expecting revenue of $140,250 and earnings of -$0.18 per share.
You can see Quiver Quantitative's $APLT stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
APPLIED THERAPEUTICS Insider Trading Activity
APPLIED THERAPEUTICS insiders have traded $APLT stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $APLT stock by insiders over the last 6 months:
- RICCARDO PERFETTI (Chief Medical Officer) has made 0 purchases and 2 sales selling 96,444 shares for an estimated $57,068.
- LESLIE D. FUNTLEYDER (See Remarks) has made 0 purchases and 2 sales selling 37,452 shares for an estimated $20,380.
- CONSTANTINE CHINOPOROS (See Remarks) has made 0 purchases and 2 sales selling 28,564 shares for an estimated $17,348.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
APPLIED THERAPEUTICS Hedge Fund Activity
We have seen 80 institutional investors add shares of APPLIED THERAPEUTICS stock to their portfolio, and 81 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- JANUS HENDERSON GROUP PLC removed 10,505,737 shares (-99.7%) from their portfolio in Q4 2024, for an estimated $8,995,012
- VESTAL POINT CAPITAL, LP added 10,355,000 shares (+904.4%) to their portfolio in Q4 2024, for an estimated $8,865,951
- SCHONFELD STRATEGIC ADVISORS LLC added 8,419,781 shares (+2458.3%) to their portfolio in Q4 2024, for an estimated $7,209,016
- PERCEPTIVE ADVISORS LLC removed 7,145,000 shares (-89.3%) from their portfolio in Q4 2024, for an estimated $6,117,549
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 5,213,370 shares (+2511.9%) to their portfolio in Q4 2024, for an estimated $4,463,687
- FRANKLIN RESOURCES INC removed 4,797,510 shares (-70.5%) from their portfolio in Q4 2024, for an estimated $4,107,628
- PROPEL BIO MANAGEMENT, LLC added 3,047,562 shares (+46.4%) to their portfolio in Q4 2024, for an estimated $2,609,322
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
